Raymond James & Associates’s MetLife MET Stock Holding History

Raymond James & Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-60,300	Closed	-$690K	–	4157
2021 Q1	$690K	Sell	60,300 -500	-0.8%	-$27.6K	﹤0.01%	2771
2020 Q4	$63K	Hold	60,800	–	–	﹤0.01%	3605
2020 Q3	$18K	Hold	60,800	–	–	﹤0.01%	3511
2020 Q2	$15K	Buy	60,800 +2,600	+4%	+$90.5K	﹤0.01%	3459
2020 Q1	$9K	Sell	58,200 -1,700	-3%	-$75.4K	﹤0.01%	3447
2019 Q4	$82K	Buy	59,900 +1,100	+2%	+$53.1K	﹤0.01%	3498
2019 Q3	$26K	Sell	58,800 -700	-1%	-$33.4K	﹤0.01%	3528
2019 Q2	$60K	Buy	59,500 +12,600	+27%	+$592K	﹤0.01%	3484
2019 Q1	$1K	Sell	46,900 -600	-1%	-$26.5K	﹤0.01%	3606
2018 Q4	$4K	Sell	47,500 -500	-1%	-$21.5K	﹤0.01%	3497
2018 Q3	$17K	Buy	48,000 +400	+0.8%	+$18.3K	﹤0.01%	3547
2018 Q2	$11K	Buy	47,600 +1,500	+3%	+$69.9K	﹤0.01%	3522
2018 Q1	$6K	Buy	46,100 +23,400	+103%	+$1.14M	﹤0.01%	3422
2017 Q4	$5K	Buy	+22,700	New	+$1.2M	﹤0.01%	3396
2016 Q2	–	Sell	-14,698	Closed	-$9K	–	3072
2016 Q1	$9K	Buy	+14,698	New	+$549K	﹤0.01%	2892

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Raymond James & Associates's MET Position: Q3 2024 in Review

Raymond James & Associates increased its MetLife (MET) stake by 3.2% in Q3 2024, buying an estimated $1.84M and bringing the position to 792,822 shares worth $65.4M. The position accounts for 0.04% of the portfolio, ranked #374.

Raymond James & Associates first reported a position in MET in Q2 2013 and has held it in 46 quarters since. The position peaked at $89.8M in Q4 2017. 1,316 funds tracked by Wall St. Rank hold MET as of Q3 2024.

Raymond James & Associates held 792,822 shares of MetLife worth $65.4M as of Q3 2024.
Raymond James & Associates bought 24,567 MetLife shares in Q3 2024, an estimated $1.84M.
MetLife made up 0.04% of Raymond James & Associates's portfolio in Q3 2024, its #374 holding.
Raymond James & Associates first reported a position in MetLife in Q2 2013 and has held it in 46 quarters since.
Raymond James & Associates's MetLife position peaked at $89.8M in Q4 2017.
1,316 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.